C K Spies1, T Bruckner2, L P Müller3, F Unglaub4,5, P Eysel3, S Löw6, M J Filbert4,5. 1. Hand Surgery, Vulpius Klinik, Vulpius Straße 29, 74906, Bad Rappenau, Germany. christianspies27@gmail.com. 2. Department of Medical Biometry and Informatics, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 305, 69120, Heidelberg, Germany. 3. Department of Orthopaedic Surgery and Traumatology, University Hospital Cologne, Kerpener Str. 62, 50937 Köln & Joseph-Stelzmann Str. 24, 50931, Köln, Germany. 4. Hand Surgery, Vulpius Klinik, Vulpius Straße 29, 74906, Bad Rappenau, Germany. 5. Medical Faculty Mannheim, Ruprecht-Karls University Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. 6. Center for Hand Surgery and Traumatology, Ledermarkt 8-10, 97980, Bad Mergentheim, Germany.
Abstract
PURPOSE: The purpose of this study was to report long-term objective and patient-reported outcome after arthroscopic debridement of central degenerative triangular fibrocartilage complex (TFCC) lesions. METHODS: A total of 17 patients with central degenerative TFCC (Palmer type 2C) lesions and ulnar positive variance who were treated by arthroscopic debridement were retrospectively reviewed. Mean follow-up was 8.8 years. Assessment facilitating the Modified Mayo Wrist score (MMWS), the Disabilities of the Arm, Shoulder, and Hand questionnaire (DASH score), recording of pain level and of patient satisfaction, and radiological examination were done. RESULTS: Patients reached a pain level of 1.7 VAS, MMW score of 92, and DASH score of 22. No significant differences could be detected between the operated and the contralateral extremity regarding range of motion and grip strength for all patients. No perioperative complications occurred. CONCLUSION: Arthroscopic debridement of central degenerative TFCC lesions is safe, reliable, and efficacious even for ulnar positive variance. LEVEL OF EVIDENCE: Therapeutic IV.
PURPOSE: The purpose of this study was to report long-term objective and patient-reported outcome after arthroscopic debridement of central degenerative triangular fibrocartilage complex (TFCC) lesions. METHODS: A total of 17 patients with central degenerative TFCC (Palmer type 2C) lesions and ulnar positive variance who were treated by arthroscopic debridement were retrospectively reviewed. Mean follow-up was 8.8 years. Assessment facilitating the Modified Mayo Wrist score (MMWS), the Disabilities of the Arm, Shoulder, and Hand questionnaire (DASH score), recording of pain level and of patient satisfaction, and radiological examination were done. RESULTS:Patients reached a pain level of 1.7 VAS, MMW score of 92, and DASH score of 22. No significant differences could be detected between the operated and the contralateral extremity regarding range of motion and grip strength for all patients. No perioperative complications occurred. CONCLUSION: Arthroscopic debridement of central degenerative TFCC lesions is safe, reliable, and efficacious even for ulnar positive variance. LEVEL OF EVIDENCE: Therapeutic IV.
Authors: Frank Unglaub; Maya B Wolf; Markus W Kroeber; Adrian Dragu; Stephan Schwarz; Thomas Mittlmeier; Oliver Kloeters; Raymund E Horch Journal: Arthroscopy Date: 2011-05-07 Impact factor: 4.772
Authors: Frank Unglaub; Susanne B Thomas; Markus W Kroeber; Adrian Dragu; Jörg Fellenberg; Maya B Wolf; Raymund E Horch Journal: Arthroscopy Date: 2009-09-17 Impact factor: 4.772
Authors: Frank Unglaub; Maya Barbara Wolf; Martin Andreas Thome; Guenter Germann; Michael Sauerbier; Andreas Reiter Journal: Arthroscopy Date: 2007-11-09 Impact factor: 4.772